Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113892 · ClinicalTrials.gov registry record · NA
Study Comparing Synthetic Vascular Grafts in Patients With Peripheral Artery Disease (PAD) Who Require Artery Bypass.
A NA study, sponsored by Maquet Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 207
- Enrollment target
NCT01113892 is a NA study that has completed, run by Maquet Cardiovascular. The registered enrollment target is 207 participants.
The verdict
NCT01113892, a NA study, has completed, sponsored by Maquet Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 207 participants
- Enrollment target
Study Summary
To demonstrate the patency and safety of vascular grafts: EXXCEL and FUSION Bioline.
Interventions
- DEVICE vascular grafts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2010-05-17 |
| Est. Completion | 2013-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01113892
The ClinicalTrials.gov registry entry for NCT01113892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maquet Cardiovascular, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vascular grafts is the first listed.
NCT01113892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01113892 about?
NCT01113892 is a clinical study titled "Study Comparing Synthetic Vascular Grafts in Patients With Peripheral Artery Disease (PAD) Who Require Artery Bypass.". To demonstrate the patency and safety of vascular grafts: EXXCEL and FUSION Bioline.
What is the current status of trial NCT01113892?
This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2010-05-17. Estimated completion is 2013-06-04.
What interventions are being tested in trial NCT01113892?
The interventions under investigation include: vascular grafts (DEVICE).
Who is sponsoring clinical trial NCT01113892?
This trial is sponsored by Maquet Cardiovascular, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.